Coya Therapeutics (COYA) Revenue & Revenue Breakdown
Coya Therapeutics Revenue Highlights
Latest Revenue (Y)
$3.55B
Latest Revenue (Q)
$163.62K
Coya Therapeutics Revenue by Period
Coya Therapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $3.55B | 59112.58% |
| 2023-12-31 | $6.00M | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | - |
Coya Therapeutics generated $3.55B in revenue during NA 2024, up 59112.58% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Coya Therapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-06-30 | $163.62K | -36.55% |
| 2025-03-31 | $257.88K | 13111.27% |
| 2024-12-31 | $1.95K | 100.00% |
| 2024-09-30 | - | -100.00% |
| 2024-06-30 | $3.42M | 2600.29% |
| 2024-03-31 | $126.84K | -97.89% |
| 2023-12-31 | $6.00M | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | - |
Coya Therapeutics generated $163.62K in revenue during Q2 2025, up -36.55% compared to the previous quarter, and up 129.00% compared to the same period a year ago.
Coya Therapeutics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| COYA | Coya Therapeutics | $3.55B | $163.62K |
| IRD | Opus Genetics | $10.99M | $4.37M |
| SRZN | Surrozen | $10.65M | $983.00K |
| TCRX | TScan Therapeutics | $2.82M | - |
| VTGN | VistaGen Therapeutics | $1.06M | $-15.00K |
| OVID | Ovid Therapeutics | $566.00K | $130.00K |
| ENTX | Entera Bio | $181.00K | $42.00K |
| CNTX | Context Therapeutics | - | - |
| NAUT | Nautilus Bio | - | - |
| ONCY | Oncolytics Biotech | - | - |